Treatment with 1000 µM of zeatin riboside induced the production of cAMP by purified CD3+ T lymphocytes to levels significantly above vehicle treated controls; cAMP production elicited by zeatin riboside exposure was similar to that induced by treatment of purified T cells with 1 µM of the well characterized, selective A2AR agonist